Target intelligence / Profile preview

Inflammatory potential

Molecular classification
Other
01

Overview

Inflammatory potential is not a specific biological molecule, receptor, or therapeutic target, but rather a qualitative or quantitative measure of a substance's capacity to elicit an inflammatory response (1). This term is frequently used in nutritional epidemiology to describe the Dietary Inflammatory Index (DII), which categorizes foods based on their effect on systemic inflammatory markers such as C-reactive protein (2). In pharmacology and toxicology, assessing the inflammatory potential of a drug candidate or nanomaterial is a critical safety parameter to ensure the agent does not trigger unintended immune activation or cytokine storms (3). Because it represents a functional outcome of various signaling pathways (such as NF-kappaB or the inflammasome) rather than a discrete protein, it does not have a unique UniProt ID or a standard druggable binding site (4). Therapeutic interventions do not target 'inflammatory potential' directly; instead, they target specific molecular drivers—like Janus kinases or TNF receptors—that contribute to the overall inflammatory state (5). References: (1) PubMed: PMC6627690; (2) NIH: National Cancer Institute; (3) Frontiers in Immunology: 'Evaluating the Inflammatory Potential of Nanomaterials'; (4) StatPearls: 'Inflammation'.

Other names
Pro-inflammatory activityInflammatory capacityDietary Inflammatory Index (DII) scoreInflammatory stimulus
02

Mechanism of action

Not applicable; this is a descriptive property of substances or physiological states rather than a molecular target.

03

Biological functions

Immune responseSignal transductionCytokine production
04

Disease associations

InflammationCancerCardiovascular diseaseMetabolic syndrome
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndrome (SIRS)Chronic low-grade inflammationHypersensitivity reactions
06

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Interleukin-1 beta (IL-1b)Fibrinogen

Beyond the preview

Go deeper on Inflammatory potential.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory potential.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call